Advertisement

Banner Fairtec GmbH Worldwide Event Solutions 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6249 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 61 62 63  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Formycon–SEVERAL: investment, 201310–201312 capital increase €9.4m 1.257m new common shares €7.5/share to existent shareholders 2013-10-28
Genetrix (ES)–SEVERAL: investment, 201310 rights offering + private placement of Sygnis AG €2.7m with 1.02m new shares €2.65/share 2013-10-28
Hana Pharmaceuticals–Paion: remimazolam, 201310– license excl €1m upfront + €2m milestones + 10% royalties for dev + manuf + commerc in Korea 2013-10-28
Biotest–SEVERAL: credit, 201310– placing of €210m notes in different tranches to more than 70 investors 2013-10-24
Celesio–McKesson: investment, 201310– acquisition €6.1b with acqu of 50.01% shares from Haniel + cash tender offer for all remaining shares €23/share 2013-10-23
Boehringer–Beactica: drug discovery services, 201310– collab expansion €na fragment-based drug discovery services for oncology-relevant kinases 2013-10-22
Heraeus–Curetis: molecular diagnostics, 201310 collab existent co-developm + co-marketing of Unyvero i60 ITI application 2013-10-22
AstraZeneca–Evotec: kidney disease drugs, 201310– license + collab agreem €na giving AZ access to selected series of molecules to treat CKD 2013-10-21
Clovis Oncology–Qiagen: molecular companion diagnostics, 201310– collab developm of therascreen EGFR RGQ PCR Kit for CO-1686 2013-10-21
Mérieux–MC Services: public relations, 201310 service existent for Transgene SA 2013-10-21
Austria (govt)–Biocom: publishing, 201310 supply service with regard to Vienna Life Science Report 2013/14 to LISAvienna by Biocom 2013-10-17
Boehringer–Vector Capital: drug discovery s/w, 201310– supply Certara D360 as drug discovery platform in Ridgefield + Biberach + Vienna 2013-10-17
Suzhou SJ Biomaterials–Scienion: print/spotting technology, 201310– distribution of Scienion products in China by Suzhou SJ Biomaterials Co Ltd 2013-10-17
Sygnature Discovery–Proteros: drug discovery services, 201310– collab strategic alliance to offer integrated services incl X-ray structure analysis 2013-10-17
Photonics Healthcare–Bavaria (govt): investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
Photonics Healthcare–High-Tech Gründerfonds: investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
Photonics Healthcare–SEVERAL: investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
CV genes-at-target project–Evotec: genomic drug target discovery, 2013– collab European ScreeningPort is partner in FP7 project 2013-10-15
CV genes-at-target project–Univ Lübeck: genomic drug target discovery, 2013– collab Univ of Lübeck is partner in FP7 project 2013-10-15
Immatics–SEVERAL: investment, 201310 financing round Series D 1st tranche €12m of €34m round Hopp + Strüngmann + Wellington Partners + MIG Funds 2013-10-15
Bayer–BioInvent: antibody library, 201310 license €na extension + broadening to n-CoDeR libraries for development of therapeutic antibodies 2013-10-14
Wilex–MC Services: public relations, 201310 service existent for Wilex AG 2013-10-10
Bayer–RWTH Aachen: bioinformatics, 201310– collab founding of Joint Research Center on Computational Biomedicine by BTS + RWTH 2013-10-09
Bayer–Sysmex: molecular companion diagnostics, 201310– collab master agreem for developm of blood-based CDx for cancer drugs by Sysmex Inostics 2013-10-09
Sartorius–PERSON: investment, 201310 existent family of the late Horst Satorius owns 50.09% bound by last will of Horst Satorius 2013-10-09
Schott–Sony: slides, 201310 collab developm + marketing of glass-plastic hybrid cell imaging slide 2013-10-07
JnJ–CureVac: vaccine technology, 201310– collab + license €na use of RNActive technology for developm of mRNA-based influenza vaccine with Crucell 2013-10-03
Merus–Akampion: public relations, 201310 service existent by Akampion 2013-10-03
Findeisen Laborbedarf–Omnilab (DE): investment, 201310 acquisition of Findeisen Laborbedarf GmbH by Omnilab-Laborzentrum GmbH & Co KG 2013-10-01
Analytik Jena–Endress+Hauser: investment, 201309– mandatory offer for remaining 52.67% of shares for €13.75/share 2013-09-27
Analytik Jena–PERSON: investment, 201309 existent founder + CEO Klaus Berka owns 9.93% 2013-09-27
Merck (DE)–Ablynx: Nanobodies, 201309– collab co-discovery + co-developm Nanobodies extension Merck Serono 2013-09-26
Panoptes Pharma–4SC: investment, 201309 4SC Discovery receives 24.9% share in Panoptics as part of license for PP-001 2013-09-26
Panoptes Pharma–4SC: PP-001, 201309– license for inflammatory eye diseases against 24.9% share in Panoptes plus milestones + royalties 2013-09-26
Indivumed–Sysmex: investment, 201309–201310 acquisition of 100% of Inostics GmbH + its subsidiary Inostics Inc by Sysmex Corp 2013-09-25
Partec–Sysmex: investment, 201309 acquisition of Partec GmbH by Sysmex Corp 2013-09-24
Myelo Therapeutics–Berlin (govt): investment, 201309 financing round Series A incl VC Fonds Technologie Berlin 2013-09-23
Myelo Therapeutics–Eckert Wagniskapital: investment, 201309 financing round Series A incl Eckert Wagniskapital und Frühphasenfinanzierung GmbH 2013-09-23
Myelo Therapeutics–JSC Valenta Pharmaceuticals: investment, 201309 financing round Series A incl JSC Valenta Pharmaceuticals 2013-09-23
Myelo Therapeutics–SEVERAL: investment, 201309 financing round Series A from VC Fonds Technologie Berlin + Eckert Wagniskapital + JSC Valenta 2013-09-23
IKFE–Columbia Healthcare Services: investment, 201309 acquisition 100% of IKFE Services GmbH which continues business of bankrupt IKFE Institut 2013-09-18
MorphoSys–SEVERAL: investment, 201309 private placement €84m with 1.5m new shares €55.76/share to institutional investors 2013-09-18
Evonik–Genedata: bioinformatics, 201309– collab expansion use of integrated Genedata offering incl Genedata Selector 2013-09-17
Microstim–SEVERAL: investment, 201309 financing round €500k MVP + HTGF + Fides Finanz-Invest 2013-09-17
Affimed–MC Services: public relations, 201309 service existent for Affimed Therapeutics AG 2013-09-16
Bruker Corp–Siscapa: SISCAPA assay technology, 201309– collab extension developm SISCAPA-MALDI workflows + installation in demo facility 2013-09-16
Rhön-Klinikum–Fresenius: investment, 201309– acquisition of 43 German hospitals for €3.07b by Fresenius Helios ANNOUNCED 2013-09-13
Evotec–Harvard Univ: drug discovery, 201309– collab €na drug discovery for ALS using iPS cells with HSCI 2013-09-12
Bayer–MIT: personalised cancer drugs, 201309– collab 5y discovery + development using oncogenomics with Broad Institute 2013-09-10
Neurodyn–Galantos: galantamine, 201309 acquisition of all assets related to Memogain® formulation of galantamine by Neurodyn 2013-09-09
Analytik Jena–Endress+Hauser: investment, 201309 capital increase €24.4m incl Endress+Hauser with resulting direct + indirect 47.33% share for E+H 2013-09-04
Analytik Jena–SEVERAL: investment, 201309 capital increase €24.4m €23.4m net 1.95m new shares €12.5/share exlusively to existent shareholders 2013-09-04
Perora–High-Tech Gründerfonds: investment, 201309 seed financing round led by HTGF 2013-09-04
Boehringer–Diaxonhit: drug discovery services, 201309– supply service €na discovery of oncology drug targets using SpliceArray platform 2013-09-03
Leukocare–SEVERAL: investment, 201309 capital increase €3.4m incl conversion of €1m corporate bond from new + existing investors 2013-09-03
EpimiRNA project–Bicoll: drug discovery technology, 201309–201808 Bicoll is project partner using its Profiles technology for drug discovery 2013-09-01
Q-Bioanalytic–EU (govt): grant, 201309–201608 FP7 grant €670k as member of DIAGMAL project 2013-09-01
Evotec–BVF Partners: investment, 201308 capital increase €30m 11.8m new shares €2.55/share to Biotechnology Value Fund LP 2013-08-31
Genfit–Bicoll: drug discovery technology, 201308 collab existent using Bicoll’s Profiles technology for target identification 2013-08-29
Life Technologies–PIKA Weihenstephan: molecular food testing, 201308– distribution of PIKA’s Fast Orange Nutrient + PCR tests for brewing + beverages 2013-08-26
Omnilab (DE)–Serva Electrophoresis: electrophoresis, 201308– distribution of Serva products + reagents by Onmilab 2013-08-22
Helmholtz–NN: mass spectrometer, 201308 supply existent use of SIMS at HZDR in Dresden 2013-08-21
Helmholtz–NN: mass spectrometer, 201308 supply installation of €3.6m SIMS at GeoForschungsZentrum Potsdam 2013-08-21
Epigenomics–Yorkville Group: investment, 201308– standby equity line up to $5m convertible bonds to be purchased 2y by YA Global Master SPV on request 2013-08-19
Eppendorf–Manufactus: manufacturing software, 201308– supply use of eKanban System IKS by Eppendorf Liquid Handling GmbH 2013-08-16
PP Wealth–SEVERAL: investment, 201308– private placement up to €32.5m of Valeado GmbH & Co KG set up by Lead Discovery Center + PP Wealth GmbH 2013-08-16
CAP-CMV GmbH–SEVERAL: investment, 201308–201403 seed/startup financing rounds €1.7m by PVP + NRW.Bank + Creathor Venture + KfW + private investors 2013-08-12
Syngenta–Caprotec: CCMS technology, 201307– supply service €na profiling interactions of new active ingredients with proteome for Syngenta 2013-08-12
Bayer–Compugen: cancer immunotherapy, 201308– collab r+d + ww excl license $10m upfront + $530m milestones + royalties against 2 targets 2013-08-05
Danone–Eurofins: food analysis, 201308– supply food testing service at least €30m revenue over 5y by newly acquired CLF 2013-08-02
Danone–Eurofins: investment, 201308 acquisition of Central Laboratories Friedichsdorf (in-house Milupa lab) by Eurofins 2013-08-02
Exelonix–High-Tech Gründerfonds: investment, 201308 seed financing from HTGF 2013-08-02
Apeiron–Rentschler: biological contract manufacturing, 201308– production + supply of APN311 for clinical studies + market 2013-08-01
Axa–Klocke: investment, 201308–201311 acquisition €na of Animal Health div of Riemser Pharma GmbH + production facility in Riems by IDT Biologika 2013-08-01
CorTec–High-Tech Gründerfonds: investment, 201308 existent HTGF is investor in CorTec GmbH 2013-08-01
E-HOD project–EU (govt): grant, 201308– grant €1.15m over 3 years 2013-08-01
NovaPump–High-Tech Gründerfonds: investment, 201307 1st financing round with HTGF 2013-07-31
Capical–SEVERAL: investment, 201307 financing Series A from M-Invest + KfW 2013-07-30
Noxxon–College Group: public relations, 201307 service existent by College Hill Life Sciences 2013-07-24
CorTec–SEVERAL: investment, 201307 2nd financing round €3m incl new investors M-Invest + KfW 2013-07-23
JenaValve–SEVERAL: investment, 201307 financing round Series C $62.5m led by Gimv 2013-07-23
Poonawalla–Deutsche Stiftung Impfstoffforschung: tuberculosis vaccine, 201307– acquisition of rights to VPM1002 by Serum Institute of India from VPM 2013-07-23
Qiagen–Exosome Diagnostics: nucleic acid sample preparation, 201307– collab excl €na developm + commerc sample prep kits for NA from exosomes 2013-07-23
Bayer–Caprotec: CCMS technology, 201307– supply service €na profiling interactions of new active ingredients for 2nd target of Bayer CropScience 2013-07-22
Caprotec–College Group: public relations, 201307 service existent by College Hill Life Sciences 2013-07-22
OctreoPharm–Eckert & Ziegler: investment, 201307 acquisition of minority interest in OctreoPharm Sciences GmbH by Eckert & Ziegler Radiopharma GmbH 2013-07-22
CI3 Cluster–Abbott: personalised immunotherapy, 201307 collab existent Abbott GmbH & Co KG is cluster partner 2013-07-21
CI3 Cluster–AdiuTide Pharmaceuticals: personalised immunotherapy, 201307 collab existent AdiuTide Pharmaceuticals GmbH is cluster partner 2013-07-21
CI3 Cluster–Aesku Diagnostics: personalised immunotherapy, 201307 collab existent Aesku Diagnostics GmbH & Co KG is cluster partner 2013-07-21
CI3 Cluster–Ageneo: personalised immunotherapy, 201307 collab existent Ageneno Life Science Experts GmbH is cluster partner 2013-07-21
CI3 Cluster–AMP-Lab: personalised immunotherapy, 201307 collab existent AMP-Lab GmbH is cluster partner 2013-07-21
CI3 Cluster–Aspiras: personalised immunotherapy, 201307 collab existent Aspiras GbR is cluster partner 2013-07-21
CI3 Cluster–Avia: personalised immunotherapy, 201307 collab existent Avia Industrial Services GmbH is cluster partner 2013-07-21
CI3 Cluster–Baimos Technologies: personalised immunotherapy, 201307 collab existent Baimos Technologies GmbH is cluster partner 2013-07-21
CI3 Cluster–Baker & McKenzie: personalised immunotherapy, 201307 collab existent Baker McKenzie is cluster partner 2013-07-21
CI3 Cluster–Baxter: personalised immunotherapy, 201307 collab existent Baxter GmbH is cluster partner 2013-07-21
CI3 Cluster–BCNP Consultants: personalised immunotherapy, 201307 collab existent BCNP Consultants GmbH is cluster partner 2013-07-21
CI3 Cluster–BioKryo: personalised immunotherapy, 201307 collab existent BioKryo GmbH is cluster partner 2013-07-21
CI3 Cluster–BioNTech: personalised immunotherapy, 201307 collab existent BioNTech AG is cluster partner 2013-07-21
CI3 Cluster–BioNTech: personalised immunotherapy, 201307 collab existent Eufets GmbH is cluster partner 2013-07-21
next pagenext page 1 2 3 4 ... 61 62 63  next pagenext page



Advertisement

Banner Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Erfolgreicher Nischenanbieter im LC/MS-Markt sucht Junior-Partner 600x60px

» top

Advertisements

Highl Successful LC/MS Niche Player Is Looking for a Junior Partner 120x240px The Events Group Pharm Connect Congress 2015 Budapest February 120x180px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px